Skip to content
MarketScale
‹ Back to IndustriesHealthcare

PRESCO’S PRODUCTS CREATE A SAFE WORKPLACE ENVIRONMENT

It’s every company’s worst nightmare: an employee falls at your factory or job site. He’s sent to the hospital with a broken leg and will miss months of work—and it turns out it’s all due to a poorly marked hazard. The irony is, for an investment of around $15 in safety marking products, this $15,000…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

It’s every company’s worst nightmare: an employee falls at your factory or job site. He’s sent to the hospital with a broken leg and will miss months of work—and it turns out it’s all due to a poorly marked hazard. The irony is, for an investment of around $15 in safety marking products, this $15,000 mistake could have been prevented. It’s clear that safety matters. That’s why Presco produces quality safety marking products to help ensure safe workspaces for all employees.

The Federal Occupational Safety and Health Administration (OSHA) has identified the “Fatal Four” causes of workplace deaths in the construction industry. They are:

  • Falls
  • Struck by object
  • Electrocutions
  • Caught-in/between

In 2016, these four categories of workplace incidents were responsible for 63.7% of the 991 fatalities in the construction industry. Falls alone caused 38.7% of these worker’s deaths. Addressing these issues is a priority for OSHA.

The agency has concluded that if the industry could eliminate the “Fatal Four,” 631 construction worker lives would be saved each year.

Safety solutions from Presco can help eliminate a huge number of fully preventable injuries and deaths due to falls. Our popular Caution and Danger Barricade Tapes help mark off an area so workers can avoid walking into a hazard. Our Pennant Flags help delineate the edges of roofs and elevated platforms to help prevent workers from falling off. Similarly, Safety Barrier Fence can help stop pedestrians from stepping into a hole. Danger Silica Tape reminds workers to put on proper personal protective equipment so they aren’t harmed by Crystalline Silica dust particles in the air.

Prioritizing safety in the workplace or job site with Presco products offers a number of key benefits. First of all, it helps protect workers from injury and illness. That, in turn, reduces absenteeism and employee turnover. Additionally, when workers see evidence that their safety is a priority, it helps raise morale, leading to increased productivity and a higher quality of work. Finally, increasing working output and reducing the costs due to workplace injury and OSHA fines will directly impact your bottom line.

A full line of marking products from Presco can help make safety a workplace priority and prevent unnecessary injuries and fatalities. For over 75 years, Presco has produced a full line of innovative safety marking products such as Barricade Tape, Marking Flags, Roll Flagging, Underground Tape, and Marking Whiskers. The majority of our products can even be custom printed to deliver your safety message and boost your brand identity. At Presco, we’re proud to be the premier manufacturer of safety marking products in the United States.

Read more at presco.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512